Fertility Services Market Size, Share, Growth, Report 2025 to 2034

Fertility Services Market Size and Growth 2025 to 2034

The global fertility services market size was valued at USD 27.64 billion in 2024 and is estimated to reach around USD 92.35 billion by 2034, growing at a compound annual growth rate (CAGR) of 12.82% during the forecast period from 2025 to 2034. The fertility services market is experiencing robust growth driven by factors such as increasing infertility rates due to changing lifestyles, delayed pregnancies, and rising prevalence of reproductive health disorders. Additionally, advancements in assisted reproductive technologies (ART), growing awareness about fertility treatments, supportive government initiatives, and the increasing number of fertility clinics globally are fueling market expansion. Moreover, shifting societal norms, greater acceptance of fertility preservation, and innovations in genetic testing further contribute to the robust growth of this market.

Fertility services represent a broad range of medical interventions, procedures, and support directed at diagnosing and treating conditions of infertility so that the person or couple might conceive. Advanced fertility techniques include IVF, intrauterine insemination, egg and sperm freezing for fertility preservation, and donor programs. Fertility services also include diagnostic assessments accompanied by hormonal treatments and surgical treatments in the treatment of the underlying conditions that have an impact on reproductive health. As ART techniques continue to evolve, these services are becoming more tailored and offering hope to those who have problems conceiving. Improving knowledge and social acceptance is making fertility services more accessible and effective worldwide, and technological advancements ensure that the journey is easier.

Fertility Services Market Report Highlights

• The Europe has recorded highest revenue share of around 35.24% in 2024.
• The North America has generated revenue share of around 31.41% in 2024.
• By type, the treatment segment has held revenue share of 51.40% in 2024.
• By end user, the fertility clinics segment was leading the market in 2024.

Fertility Services Market Growth Factors

• Rising Infertility Rates: Changing lifestyles, increased stress levels, and environmental factors have been the main drivers of increased infertility rates. These include obesity, sedentary lifestyles, delayed pregnancies, and smoking, which have led to increased infertility rates across the globe. For instance, it has been estimated that around 15% of couples are infertile, and such statistics have proven to be on the rise over time. This shows that demand for advanced fertility treatments such as IVF, ICSI, and fertility preservation methods is rising and fueling the fertility services industry growth.
• Advances in ART: Advances in ART, such as IVF, ICSI, and freezing of eggs, have led to marked improvements in efficiency and success of the processes.These advance treatments reduce the cycles of treatment required and the accompanying costs, attracting a wider customer base. An example is time-lapse imaging with AI-driven selection of embryos by clinicians to spot those with the highest implantation potential. Further growth in the market is expected by increasing accessibility and affordability of technologies.
• Increased Awareness Over Fertility Treatment: Public campaigns and education done by governments, non-profits, and medical service providers to raise awareness have significantly increased people's knowledge over infertility and the respective treatments. People are being targeted to reduce stigmas against fertility issues to visit doctors with their partners for medical advice. In addition, information related to the option of treatment, the charges for it, and success rates are well highlighted by digital platforms and social media. Increased awareness has also led to early diagnosis and timely intervention; this has driven demand for fertility services globally.

Fertility Services Market Trends

• Market Trend Rise of Fertility Preservation Services: With people opting to delay parenthood for career or other goals, the fertility preservation services such as egg freezing, sperm freezing, and embryo freezing are in the ascent. As increasing numbers of people want flexibility in planning their families without losing their fertility potentials, Fertility Preservation Services are witnessed to be growing. This trend is most pronounced in women between the late 20s and early 30s as more women are now becoming increasingly aware of the fact that their biological fertility starts declining with age. This trend is fueling the cryopreservation and related technologies market.
• Artificial Intelligence in Fertility Services: The role of artificial intelligence in fertility services is increasing, especially in the selection of embryos and predictive analytics.AI-driven tools are able to scan large amounts of data in order to analyze embryos with the best potential to successfully implant and improve success rates. For example, AI-based time-lapse imaging systems are improving embryologists' decisions. All this is bound to make things much easier, reduce cycles, and yield better results; this will encourage more adoption of fertility services.
• Home Fertility Testing Kits: At-home fertility testing kits have become popular, and this has made it easier for people to monitor their fertility health. These kits give insights into key factors like hormone levels, sperm count, and ovulation cycles, thus enabling early diagnosis of potential issues. Companies offering these kits usually pair them with telehealth consultations for a seamless experience. This has enabled consumers to take action and seek proper treatments for their fertility issues as well as being informed of their treatment options.

Report Scope

Fertility Services Market Dynamics

Market Drivers

• Increasing Infertility Trends: Global infertility levels are increasing through lifestyle changes, childbearing at old ages, increased stress, high obesity levels, and the higher prevalence of disease conditions like polycystic ovary syndrome and endometriosis. It is also being attributed to other environmental pollutants, as well as the decline of sperm counts in males. The rising incidence of infertility leads to an increase in the number of people requiring fertility treatments, which include ART like IVF and IUI. This rising number of couples seeking medical assistance to conceive has placed the fertility services market at the center of healthcare segments and has therefore accelerated technological developments as well as an increase in the number of fertility clinics globally.
• Egg Freezing Market Expands: Egg freezing, or oocyte cryopreservation, has gained popularity as a service mainly by women who prefer delaying the birth for professional, health, or personal reasons. The boom is due to improved cryopreservation technology that increases the percentage of thawing and fertilization. Corporations and organizations are also incorporating egg freezing in their fertility benefit packages. The increasing adoption of the procedure among cancer patients who want to preserve fertility before undergoing treatments such as chemotherapy has contributed further to its increasing demand. This reflects the trend towards proactive fertility management and is a driving force for growth within the overall fertility services sector.
• Global Infertility Awareness Programs: Infertility awareness campaigns run by the government, health and welfare organizations, and non-profits have informed the public of the causes of infertility and its treatment options. This reduces the stigma associated with the disease, encourages people to seek diagnosis at an early stage, and equips them on matters of reproductive health. Examples include World Infertility Awareness Month and outreach activities. All these efforts have opened up accessibility to fertility services in areas lacking such services, and individuals approach medical assistance to seek a way out. Campaigns addressing misconceptions and the necessity of treatment serve as a driver for growth in the fertility services market.

Market Opportunities

• Growing IVF awareness: Growing awareness of IVF as a possible solution to infertility presents an opportunity in the fertility services market. Public awareness campaigns, education, and social media are helping bring down stigma associated with infertility. Increased people are being pushed toward treatment due to the eliminated stigma.Celebrities endorsing and success stories further normalized IVF, which also increased acceptance. The improved awareness has also led to problems in fertility getting diagnosed at earlier stages. And with that, patients are being referred for more advanced treatments such as IVF much earlier in their courses. This upsurge of demand for IVF services by the developing world itself would pose a massive growth opportunity for the fertility clinics and service providers worldwide.
• Advances in Genetics Testing: Newer genetic tests like those used with preimplantation testing help expand possibilities with this market. PGT is a methodology where clinicians examine embryos for known abnormalities; it increases their chances of obtaining a healthy outcome and successful birth when embryos are implanted after testing. Greater accuracy and relative economies of next-generation sequencing have increased this testing in treatment for infertility services. These developments are particularly helpful for those with genetic disorders in the family history or habitual miscarriages. Inclusion of genetic testing into the fertility care is beneficial in building up the confidence of patients in treatment outcomes, therefore more people visiting for assisted reproductive technologies.

Market Restraints

• Expensive Fertility Treatments: Most fertility treatments such as IVF are expensive, thereby making them unreachable for many. Especially in lower-income groups, the cost will be a hindrance. For instance, the cost of an IVF cycle in the U.S. varies between USD 12,000 and USD 15,000, not including medication. For couples that need more than one cycle, the cost is enormous. In addition, limited insurance coverage makes it impossible for most people, especially in developing regions, to access these treatments. This is a major deterrent to market growth.
• Ethical and Religious Issues: Ethical and religious concerns regarding fertility treatments, especially ART procedures such as embryo freezing, surrogacy, and genetic testing, are some of the factors limiting the growth of the market in some regions. For example, certain religious groups have termed some practices like in vitro fertilization and third-party reproduction controversial or unethical. Embryo selection and disposal have created ethical issues in some countries, which has made them implement stricter regulations, further limiting the adoption of fertility services. These issues also challenge the general societal acceptance of fertility treatments.

Market Challenges

• High cost of treatment: The cost of treatment including IVF, egg freezing, and even other genetic testing is very high, a significant barrier to the fertility services market. Most people cannot afford the many cycles needed for success, given that insurance does not cover fertility treatment in most parts of the world. These costs cover medication, consultation, lab fees, and embryo preservation, which can rapidly add up. In developing countries, where available disposable income is much lower, it places a significant limit on access to such fertility treatments for the significant majority of people.
• Ethical and Religious Issues: Fertility services market has numerous ethical and religious issues, particularly in countries that have areas of high religious or cultural belief. IVF, freezing embryos, and using gametes for donor purposes create a few ethical issues about life's sanctity and genetic manipulations. For example, some religions have an issue with the creation of embryos outside the body or destruction of unused embryos. These concerns may result in hesitation by the members of such communities toward assisted reproductive technologies, which restricts the further growth of this market in such regions. Thus, the fertility treatments require sensitiveness and culturally aware approaches for dealing with such concerns.

Fertility Services Market Segmental Analysis

The fertility services market is segmented into type, procedure, services, end-user and region. Based on type, the market is classified into diagnosis, treatment and preservation. Based on procedure, the market is classified into assisted reproductive technology (ART), in-vitro fertilization (IVF), artificial insemination, surrogacy and others. Based on services, the market is classified into donor services and non-donor services. Based on end user, the market is classified into fertility clinics, hospitals, clinical research institutes and surgical centers.

Type Analysis

Based on type, the treatment segment accounted for a highest revenue share in 2024. The treatment segment is classified into In-vitro fertilization (IVF) and artificial insemination.

The preservation segment is projected to grow at a lucrative CAGR over the forecast period. The preservation segment is classified into egg & embryo freezing and sperm banking.

Procedure Analysis

ART: ART comprises all those medical interventions aimed at assisting an individual or a couple in the reproductive process. In ART, egg and sperm management is conducted as treatments for infertility through procedures like IVF, artificial insemination, and surrogacy. Through many inventions of modern ART techniques, its effectiveness has greatly increased to achieve a desired level of fertility outcome. Thus, most fertility treatments focus on different cases of infertility with male or female factors, for which it serves a fundamental part in managing such infertility conditions.

In-vitro fertilization (IVF): This is one of the most successful and sought-after ART treatments for reproductive support. IVF includes fertilizing the egg outside the human body and then transplanting the embryo into the uterus. IVF has a high success rate but is costly and often requires more than one cycle, usually following other methods such as genetic testing. It can be used to treat many causes of infertility, including tubal obstruction, male factor, and even an older woman's declining fertility with age.

Artificial Insemination: This is a technique whereby sperms are directly introduced into the woman's reproductive system, avoiding the natural barriers to conception. It is used mainly when male infertility exists or in cases where sperm donation insemination is to be used, or other forms of ARTs are not needed. It is less invasive and cheaper than IVF but its success rate is lower. The procedure may be performed either with or without the administration of medications that stimulate ovulation, based on the condition of the patient.

Surrogacy: This is a method in which a woman carries a pregnancy for someone or a couple unable to conceive or carry a pregnancy. There are two kinds: traditional surrogacy, which involves using a surrogate's own eggs, and gestational surrogacy, whose eggs may originate from the intending mother or even a donor. Surrogacy is a complex subject because it involves legal, medical, and emotional aspects and is broadly applied when women cannot carry a pregnancy due to health issues.

Others: Other fertility services include the following: treatments such as freezing of eggs, freezing of sperms, freezing of embryos, and genetic screening. Such services allow one to keep reproductive material to be used later. This gives much freedom to individuals who may desire to delay getting a family or who may be faced with infertility later in life.

Services Analysis

Donor Services: This is a service offering eggs, sperm, or embryos to people or couples who are not able to produce viable reproductive cells because of infertility issues or genetic disorders. Donor services are used in ART, particularly in IVF, to facilitate conception. Many fertility centers provide anonymous or known donor services and, in some cases, even offer genetic screening for the health of the gametes of the donor. Demand for donor services is surging among single-parent or same-sex couples thus propelling the market.

Non-donor Services: Such services are services where the reproductive material of a patient or a couple is applied to treat the issue of fertility. This type of service pertains to ART methods such as IVF and AI in which a third-party contribution is not essential to treat infertility. Patients who can see biological offspring but are failing to do so because of age or hormonal imbalances, or issues of male factor infertility, have an inclination towards these non-donor services.

End-User Analysis

Fertility Clinics: They are specialized health centers that offer fertility services, among them, ART, IVF, among others. These tend to be the first places most people or their couples come for fertility care because they are usually more individualized. Fertility clinics are very advanced, having all the high-tech equipment like: sperm and egg retrieval laboratories and embryo culture. The number of fertility clinics is mushrooming globally, thus increasing the accessibility of services to a greater population of patients because of increasing demand for fertility services.

Hospitals: Many hospitals also offer fertility treatments, especially in larger specialized departments. The medical equipment here is more developed, and the staff are better trained. This is a more popular option among patients with more serious medical conditions, such as those who have cancer and want to preserve their fertility or women with various health problems. They might partner with fertility clinics to provide ART services within an integrated approach to healthcare.

Clinical Research Institutes: Clinical research institutes are crucial for furthering fertility treatments based on research and clinical trials. They focus mainly on developing new fertility technologies, improving treatment success rates for treatments like IVF, and improving techniques regarding genetic screening. They are usually in alliance with pharmaceutical companies and universities to develop new drugs, procedures, and techniques. Research centers give the impetus to expand fertility treatments, including stem cell research, genetic testing, and fertility plans tailored to the individual.

Surgical Centers: These are specialized medical centers conducting outpatient surgical procedures, such as issues concerned with fertility.These centers can include the retrieving of eggs, sperm retrieval, or surgery for endometriosis or other conditions, such as blocked fallopian tubes, which may impair one's ability to conceive. Even many surgeries are used through surgical centers on more minor occasions that also might not cause lengthy recovery sessions afterward. Also, surgical fertility facilities are dedicated locations for patient operations that aim directly at producing surgically assisted infusions.

Fertility Services Market Regional Analysis

The fertility services market can be segmented into the following key regions: North America, Europe, Asia-Pacific, and LAMEA (Latin America, Middle East, and Africa). Each of these regions is described in further detail as follows.

North America Fertility Services Market Trends

The region is characterized by superior healthcare infrastructure, high awareness of infertility treatments, and higher disposable income. The well-established fertility clinics, new and advanced technologies of reproductive assisted like IVF, and high adoption of donation services of both eggs and sperms are contributing growth factors to this market. Along with these drivers, the favorably regulatory setting of North America and government backing for ART technology further supports its expansion. With women increasingly delaying pregnancies for career or other lifestyle reasons, there is increasing demand for preservation of fertility.

Why Europe accounts for highest market shares in fertility services market?

The Europe region accounts for one of the highest market shares. Germany, UK, and France are some of the countries involved. Improving health care systems as well as awareness of fertility problems have resulted in increased demand for ART services. For example, the UK and Germany's fertility treatment markets are heavily regulated to allow a patient to reach state-of-the-art medical technology. On the other hand, varying laws of European countries such as prohibition of freezing embryos or genetic testing might have an impact on the services that are available and the patients who can access it. Another reason for the increase in the fertility services market in Europe is the increasing rate of late childbearing among women.

What factors are contributing highest growth for Asia-Pacific fertility services market? 

The market is one of the promising markets in the Asia-Pacific region primarily because disposable incomes are increasing, social attitudes are altering, and awareness of fertility treatments is growing. The infertility rates in China, India, Japan, and South Korea are rising. So are the numbers of couples going in for IVF. Some areas are even shunned from discussions and awareness programs. As the incidence of infertility rises and the access to health facilities expands, coupled with the governments' reproductive health promotional strategies, the fertility services market is also seeing an increase in the Asia-Pacific region.

LAMEA Fertility Services Market Trends

The market is growing in the LAMEA region, Latin America, Middle East, and Africa, though less than that in North America and Europe. Countries in Latin America, from Brazil to Mexico and Argentina, have made giant strides in fertility treatments, with growing awareness and better access to ART. On the other hand, advanced fertility treatments in the Middle East, mainly in the UAE and Saudi Arabia, are highly becoming acceptable to modernize conventional beliefs within cultural and religious confines. The African market is still very small, yet services are few and far between, but it has growing interest in fertility treatment options.

Fertility Services Market Top Companies

• Olympus Corporation
• The Cooper Companies Inc.
• Instituto Bernabeu
• VirtusHealth
• CooperSurgical, Inc.
• Vitrolife
• Care Fertility
• INVO Bioscience
• Monash IVF
• Fertility Focus Limited
• Carolinas Fertility Institute
• Apollo Hospitals Enterprise Ltd.
• Merck KGaA
• LABOTECT GMBH
• Medicover AB

CEO Statements

Bruce Shook, CEO of TMRW Life Sciences

"Investments into fertility startups have reached an all-time high, up 89% from the previous year. Despite declining birth rates, interest in fertility services has surpassed pre-pandemic levels."

Dr. Helen O'Neill, CEO of Hertility Health

"Fundraising for our women's health start-up has been as painful as giving birth, but it’s worth it to provide at-home hormone health and fertility testing that reduces the time to diagnosis for conditions like endometriosis."

Recent Developments

• In April 2023, Cryoport, Inc. signed a three-year supply chain agreement with Boston IVF to streamline the transportation of reproductive materials across the United States. This partnership focuses on ensuring the safe and efficient delivery of critical biological samples, including eggs, sperm, and embryos, which are vital for fertility treatments.
• In October 2022, Maven Clinic, a U.S.-based telemedicine and virtual clinic provider specializing in women’s and family health, partnered with Indira IVF, an India-based infertility clinic chain. This collaboration aims to provide Maven's members in India with access to Indira IVF's high-quality fertility care, expanding support for family-building services with access to Indira IVF's high-quality fertility care, expanding support for family-building services.

Market Segmentation

By Type

• Diagnosis
  
  • Male Infertility
    
    • DNA Fragmentation Technique
    • Oxidative Stress Analysis
    • Microscopic Examination
    • Sperm Agglutination
    • Computer Assisted Semen Analysis
    • Sperm Penetration Assay
    • Others
  • Female Infertility
    
    • Ovarian reserve testing
    • Hysterosalpingography
    • Hormone testing
    • Other Tests
• Treatment
• Preservation
  
  • Egg & Embryo Freezing
  • Sperm Banking

By Procedure 

• Assisted Reproductive Technology (ART)
• In-Vitro Fertilization (IVF)
• Artificial Insemination
• Surrogacy
• Others

By Services 

• Donor Services
• Non-donor Services

By End-User 

• Fertility Clinics
• Hospitals
• Clinical Research Institutes
• Surgical Centers

By Region

• North America
• APAC
• Europe
• LAMEA